Is Janssen Pharmaceuticals, Inc. FDA approved?

Janssen Pharmaceuticals, Inc. holds no registered establishment of its own; 149 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.

What drugs does Janssen Pharmaceuticals, Inc. make?

149 products are listed under Janssen Pharmaceuticals, Inc. in the openFDA NDC Directory, most often as tablet, film coated; injection; powder. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Are any Janssen Pharmaceuticals, Inc. products in shortage?

4 presentations are currently listed in the FDA drug shortage database under Janssen Pharmaceuticals, Inc., covering Methylphenidate Hydrochloride Tablet, Extended Release.

Janssen Pharmaceuticals, Inc.

Data as of 24 Sept 2026 · How to read this entry

Request a quote Claim this profile

Registered sites: 0
Active NDC listings: 149
Labeller names: 9
Live patents: 234
Exclusivities: 10
Shortage listings: 8
Countries: 0

Alert

Drug shortage listings

Drug	Presentation	Status	Availability	Posted / updated
Methylphenidate Hydrochloride Tablet, Extended ReleasePsychiatry	Concerta, Tablet, Extended Release, 36 mg (NDC 50458-586-01)	Current	Available	26 Jul 202317 Sept 2026
Methylphenidate Hydrochloride Tablet, Extended ReleasePsychiatry	Concerta, Tablet, Extended Release, 18 mg (NDC 50458-585-01)	Current	Available	26 Jul 202317 Sept 2026
Methylphenidate Hydrochloride Tablet, Extended ReleasePsychiatry	Concerta, Tablet, Extended Release, 27 mg (NDC 50458-588-01)	Current	Available	26 Jul 202317 Sept 2026
Methylphenidate Hydrochloride Tablet, Extended ReleasePsychiatry	Concerta, Tablet, Extended Release, 54 mg (NDC 50458-587-01)	Current	Available	26 Jul 202317 Sept 2026
Rivaroxaban For SuspensionHematology	Xarelto, For Suspension, 155 mg (NDC 50458-575-01)	To Be Discontinued	-	18 Sept 202618 Sept 2026
Itraconazole CapsuleAnti-Infective, Other	Sporanox, Capsule, 100 mg (NDC 50458-290-01)	To Be Discontinued	-	27 Feb 202627 Feb 2026
Itraconazole CapsuleAnti-Infective, Other	Sporanox, Capsule, 100 mg (NDC 10147-1700-3)	To Be Discontinued	-	27 Feb 202627 Feb 2026
Itraconazole CapsuleAnti-Infective, Other	Sporanox, Capsule, 100 mg (NDC 50458-290-04)	To Be Discontinued	-	27 Feb 202627 Feb 2026

Catalogue

Drug listings by form and route

149

149 active NDC listings: 130 human prescription drug, 15 bulk ingredient, 3 drug for further processing, 1 cellular therapy. By marketing category: NDA 95, BLA 36, BULK INGREDIENT 15, DRUG FOR FURTHER PROCESSING 3.

Dosage form	NDCs
tablet, film coated	30
injection	20
powder	15
injection, solution	13
tablet	11
solution	9
tablet, extended release	8
injection, suspension, extended release	6
kit	6
tablet, orally disintegrating	5
injection, solution, concentrate	4
tablet, coated	4
tablet, film coated, extended release	4
injection, powder, lyophilized, for solution	3
capsule, coated pellets	2

Route	NDCs
oral	73
subcutaneous	24
intravenous	20
intramuscular	13
intravesical	1
nasal	1

Labeller name on the listing	NDCs
janssen pharmaceuticals, inc.	57
janssen biotech, inc.	36
janssen products, lp	17
janssen pharmaceutica nv	16
janssen products lp	12
janssen pharmaceuticals, inc	8
janssen biotech, inc	1
janssen pharmaceutica, nv	1
janssen pharmaceutical nv	1

Exclusivity

Patents and exclusivities

234

Patent	Product	Covers	Expiry
7700645	PREZCOBIX, PREZISTA, SYMTUZAcobicistat; darunavir ethanolate; cobicistat; darunavir; emtricitabine; tenofovir alafenamide fumarate; darunavir	substance, product	Dec 2026
9592207	SPRAVATOesketamine hydrochloride	use	Mar 2027
8802689	ERLEADAapalutamide	use	Mar 2027
9388159	ERLEADAapalutamide	substance, product	Mar 2027
9987261	ERLEADAapalutamide	product	Mar 2027
7700645*PED	PREZCOBIX, PREZISTAcobicistat; darunavir ethanolate; darunavir	use	Jun 2027
7943788	INVOKAMET, INVOKAMET XR, INVOKANAcanagliflozin; canagliflozin; metformin hydrochloride	substance, product	Jul 2027
8071579	AKEEGAabiraterone acetate; niraparib tosylate	use	Aug 2027
8143241	AKEEGAabiraterone acetate; niraparib tosylate	use	Aug 2027
8513202	INVOKAMET, INVOKAMET XR, INVOKANAcanagliflozin; canagliflozin; metformin hydrochloride	substance, product	Dec 2027
8895557	YONDELIStrabectedin	product	Jan 2028
7943788*PED	INVOKAMET, INVOKAMET XR, INVOKANAcanagliflozin; canagliflozin; metformin hydrochloride	use	Jan 2028
8513202*PED	INVOKAMET, INVOKAMET XR, INVOKANAcanagliflozin; canagliflozin; metformin hydrochloride	use	Jun 2028
8895557*PED	YONDELIStrabectedin	use	Jul 2028
7943582	INVOKAMET, INVOKAMET XR, INVOKANAcanagliflozin; canagliflozin; metformin hydrochloride	substance, product	Feb 2029
8436185	AKEEGAabiraterone acetate; niraparib tosylate	substance, product	Apr 2029
7943582*PED	INVOKAMET, INVOKAMET XR, INVOKANAcanagliflozin; canagliflozin; metformin hydrochloride	use	Aug 2029
8148374	PREZCOBIX, SYMTUZAcobicistat; darunavir ethanolate; cobicistat; darunavir; emtricitabine; tenofovir alafenamide fumarate	substance, product	Sept 2029
8148399	OLYSIOsimeprevir sodium	substance, product	Sept 2029
12403086	INLEXZOgemcitabine hydrochloride	product	Jun 2030
11576894	INVOKAMETcanagliflozin; metformin hydrochloride	product	Jul 2030
12576253	INLEXZOgemcitabine hydrochloride	product	Dec 2030
9439906	INVEGA SUSTENNApaliperidone palmitate	use	Jan 2031
8071623	AKEEGAabiraterone acetate; niraparib tosylate	substance, product	Mar 2031
9464071	BALVERSAerdafitinib	use	Apr 2031
8859562	AKEEGAabiraterone acetate; niraparib tosylate	use	Aug 2031
8445507	ERLEADAapalutamide	substance, product	Feb 2032
8679094	INLEXZOgemcitabine hydrochloride	product	Apr 2032
8754065	SYMTUZAcobicistat; darunavir; emtricitabine; tenofovir alafenamide fumarate	substance, product	Aug 2032
9296769	SYMTUZAcobicistat; darunavir; emtricitabine; tenofovir alafenamide fumarate	substance, product	Aug 2032
10039718	PREZCOBIX, SYMTUZAcobicistat; darunavir ethanolate; cobicistat; darunavir; emtricitabine; tenofovir alafenamide fumarate	product	Oct 2032
8785500	SPRAVATOesketamine hydrochloride	use	Mar 2033
8895601	BALVERSAerdafitinib	substance, product	Apr 2033
9481663	ERLEADAapalutamide	substance, product	Jun 2033
10849888	ERLEADAapalutamide	use	Sept 2033
9884054	ERLEADAapalutamide	use	Sept 2033
RE49353	ERLEADAapalutamide	use	Sept 2033
RE50642	ERLEADAapalutamide	use	Sept 2033
9539218	XARELTOrivaroxaban	use	Feb 2034
11446260	SPRAVATOesketamine hydrochloride	use	Mar 2034
9539218*PED	XARELTOrivaroxaban	use	Aug 2034
10729823	INLEXZOgemcitabine hydrochloride	product	Aug 2034
12447241	INLEXZOgemcitabine hydrochloride	product	Aug 2034
9902714	BALVERSAerdafitinib	product	Mar 2035
10869844	SPRAVATOesketamine hydrochloride	use	Sept 2035
11173134	SPRAVATOesketamine hydrochloride	use	Sept 2035
11311500	SPRAVATOesketamine hydrochloride	use	Sept 2035
9593098	LAZCLUZElazertinib mesylate	substance, product	Oct 2035
RE50528	LAZCLUZElazertinib mesylate	substance, product	Oct 2035
12037644	BALVERSAerdafitinib	use	Oct 2035
12303493	ERLEADAapalutamide	product	Dec 2035
10898482	BALVERSAerdafitinib	product	Feb 2036
11684620	BALVERSAerdafitinib	use	Feb 2036
10143693	INVEGA TRINZApaliperidone palmitate	use	Apr 2036
12678498	BALVERSAerdafitinib	use	Jun 2036
10478494	BALVERSAerdafitinib	use	Aug 2036
11207311	AKEEGAabiraterone acetate; niraparib tosylate	use	Jul 2037
11986468	AKEEGAabiraterone acetate; niraparib tosylate	use	Jul 2037
11986469	AKEEGAabiraterone acetate; niraparib tosylate	use	Jul 2037
11986470	AKEEGAabiraterone acetate; niraparib tosylate	use	Jul 2037

Product	Exclusivity	Until
AKEEGAABIRATERONE ACETATE; NIRAPARIB TOSYLATE	I-980 New indication	Dec 2028
BALVERSAERDAFITINIB	I-930 New indication	Jan 2027
EDURANT PEDRILPIVIRINE HYDROCHLORIDE	PED Paediatric	Sept 2027
ICOTYDEICOTROKINRA HYDROCHLORIDE	NCE New chemical entity	Mar 2031
INLEXZOGEMCITABINE HYDROCHLORIDE	NP New product	Sept 2028
INVOKAMETCANAGLIFLOZIN; METFORMIN HYDROCHLORIDE	PED Paediatric	Jun 2028
INVOKAMET XRCANAGLIFLOZIN; METFORMIN HYDROCHLORIDE	PED Paediatric	Jun 2028
INVOKANACANAGLIFLOZIN	PED Paediatric	Jun 2028
LAZCLUZELAZERTINIB MESYLATE	NCE New chemical entity	Aug 2029
SPRAVATOESKETAMINE HYDROCHLORIDE	I-959 New indication	Jan 2028

Catalogue

Marketed products

149

Brand	Generic name	Form / route	NDC
AKEEGA	NIRAPARIB TOSYLATE MONOHYDRATE and ABIRATERONE ACETATE	tablet, film coated, oral	57894-050NDA
AKEEGA	NIRAPARIB TOSYLATE MONOHYDRATE and ABIRATERONE ACETATE	tablet, film coated, oral	57894-100NDA
-	Abiraterone Acetate	powder	12578-619BULK INGREDIENT
-	Apalutamide	powder	12578-621BULK INGREDIENT
BALVERSA	Erdafitinib	tablet, film coated, oral	59676-030NDA
BALVERSA	Erdafitinib	tablet, film coated, oral	59676-040NDA
BALVERSA	Erdafitinib	tablet, film coated, oral	59676-050NDA
-	Buprenorphine	powder	12578-607BULK INGREDIENT
-	Buprenorphine Hydrochloride	powder	12578-608BULK INGREDIENT
CARVYKTI	ciltacabtagene autoleucel	injection, suspension, intravenous	57894-111BLA
CONCERTA	Methylphenidate hydrochloride	tablet, extended release, oral	50458-585NDA
CONCERTA	Methylphenidate hydrochloride	tablet, extended release, oral	50458-586NDA
CONCERTA	Methylphenidate hydrochloride	tablet, extended release, oral	50458-587NDA
CONCERTA	Methylphenidate hydrochloride	tablet, extended release, oral	50458-588NDA
-	Canagliflozin	powder	12578-611BULK INGREDIENT
-	Canagliflozin	powder	12578-615BULK INGREDIENT
DARZALEX	Daratumumab	injection, solution, concentrate, intravenous	57894-502BLA
Darzalex Faspro	daratumumab and hyaluronidase-fihj (human recombinant)	injection, subcutaneous	57894-503BLA
Darzalex IV	Daratumumab	injection, solution, concentrate, intravenous	57894-505BLA
EDURANT	rilpivirine hydrochloride	tablet, film coated, oral	59676-278NDA
EDURANT PED	rilpivirine hydrochloride	tablet, for suspension, oral	59676-280NDA
ELMIRON	PENTOSAN POLYSULFATE SODIUM	capsule, gelatin coated, oral	50458-098NDA
ERLEADA	Apalutamide	tablet, film coated, oral	59676-600NDA
ERLEADA	Apalutamide	tablet, film coated, oral	59676-604NDA
-	Galantamine hydrobromide	powder	12578-890BULK INGREDIENT
Haldol Decanoate	Haloperidol Decanoate	injection, intramuscular	50458-253NDA
Haldol Decanoate	Haloperidol Decanoate	injection, intramuscular	50458-254NDA
-	Haloperidol	powder	12578-617BULK INGREDIENT
ICOTYDE	icotrokinra	tablet, film coated, oral	57894-201NDA
IMAAVY	nipocalimab-aahu	injection, solution, concentrate, intravenous	57894-800BLA
IMAAVY	nipocalimab-aahu	injection, solution, concentrate, intravenous	57894-801BLA
INFLIXIMAB	INFLIXIMAB	injection, powder, lyophilized, for solution, intravenous	57894-160BLA
INLEXZO	gemcitabine intravesical	system, intravesical	57894-225NDA
INVEGA	paliperidone	tablet, extended release, oral	50458-550NDA
INVEGA	paliperidone	tablet, extended release, oral	50458-551NDA
INVEGA	paliperidone	tablet, extended release, oral	50458-552NDA
INVEGA	paliperidone	tablet, extended release, oral	50458-554NDA
INVEGA HAFYERA	paliperidone palmitate	injection, suspension, extended release, intramuscular	50458-611NDA
INVEGA HAFYERA	paliperidone palmitate	injection, suspension, extended release, intramuscular	50458-612NDA
INVEGA SUSTENNA	paliperidone palmitate	injection, intramuscular	50458-560NDA
INVEGA SUSTENNA	paliperidone palmitate	injection, intramuscular	50458-561NDA
INVEGA SUSTENNA	paliperidone palmitate	injection, intramuscular	50458-562NDA
INVEGA SUSTENNA	paliperidone palmitate	injection, intramuscular	50458-563NDA
INVEGA SUSTENNA	paliperidone palmitate	injection, intramuscular	50458-564NDA
INVEGA TRINZA	paliperidone palmitate	injection, suspension, extended release, intramuscular	50458-606NDA
INVEGA TRINZA	paliperidone palmitate	injection, suspension, extended release, intramuscular	50458-607NDA
INVEGA TRINZA	paliperidone palmitate	injection, suspension, extended release, intramuscular	50458-608NDA
INVEGA TRINZA	paliperidone palmitate	injection, suspension, extended release, intramuscular	50458-609NDA
INVOKAMET	canagliflozin and metformin hydrochloride	tablet, film coated, oral	50458-540NDA
INVOKAMET	canagliflozin and metformin hydrochloride	tablet, film coated, oral	50458-541NDA
INVOKAMET	canagliflozin and metformin hydrochloride	tablet, film coated, oral	50458-542NDA
INVOKAMET	canagliflozin and metformin hydrochloride	tablet, film coated, oral	50458-543NDA
INVOKAMET XR	canagliflozin and metformin hydrochloride	tablet, film coated, extended release, oral	50458-940NDA
INVOKAMET XR	canagliflozin and metformin hydrochloride	tablet, film coated, extended release, oral	50458-941NDA
INVOKAMET XR	canagliflozin and metformin hydrochloride	tablet, film coated, extended release, oral	50458-942NDA
INVOKAMET XR	canagliflozin and metformin hydrochloride	tablet, film coated, extended release, oral	50458-943NDA
INVOKANA	canagliflozin	tablet, film coated, oral	50458-140NDA
INVOKANA	canagliflozin	tablet, film coated, oral	50458-141NDA
-	Icotrokinra	powder	12578-623BULK INGREDIENT
Intelence	etravirine	tablet, oral	59676-570NDA
Intelence	etravirine	tablet, oral	59676-571NDA
Intelence	etravirine	tablet, oral	59676-572NDA
-	Itraconazole	powder	12578-299BULK INGREDIENT
LAZCLUZE	lazertinib	tablet, film coated, oral	57894-080NDA
LAZCLUZE	lazertinib	tablet, film coated, oral	57894-240NDA
-	Loperamide hydrochloride	powder	12578-409BULK INGREDIENT
-	Mebendazole	powder	12578-618BULK INGREDIENT
-	Miconazole Nitrate	powder	12578-488BULK INGREDIENT
-	POLYETHYLENE GLYCOL 400	solution	12578-115DRUG FOR FURTHER PROCESSING
-	POLYETHYLENE GLYCOL 400	solution	12578-119DRUG FOR FURTHER PROCESSING
PONVORY	Ponesimod	kit	50458-707NDA
PONVORY	Ponesimod	tablet, film coated, oral	50458-720NDA
PREZCOBIX	DARUNAVIR ETHANOLATE and COBICISTAT	tablet, film coated, oral	59676-575NDA
PREZCOBIX	DARUNAVIR ETHANOLATE and COBICISTAT	tablet, film coated, oral	59676-578NDA
PREZCOBIX PED	DARUNAVIR ETHANOLATE and COBICISTAT	tablet, for suspension, oral	59676-577NDA
PREZISTA	darunavir	tablet, film coated, oral	59676-562NDA
PREZISTA	darunavir	tablet, film coated, oral	59676-563NDA
PREZISTA	darunavir	tablet, film coated, oral	59676-564NDA
PREZISTA	darunavir	suspension, oral	59676-565NDA
PREZISTA	darunavir	tablet, film coated, oral	59676-566NDA
PROCRIT	Erythropoietin	injection, solution, intravenous, subcutaneous	59676-302BLA
PROCRIT	Erythropoietin	injection, solution, intravenous, subcutaneous	59676-303BLA
PROCRIT	Erythropoietin	injection, solution, intravenous, subcutaneous	59676-304BLA
PROCRIT	Erythropoietin	injection, solution, intravenous, subcutaneous	59676-310BLA
PROCRIT	Erythropoietin	injection, solution, intravenous, subcutaneous	59676-312BLA
PROCRIT	Erythropoietin	injection, solution, intravenous, subcutaneous	59676-320BLA
PROCRIT	Erythropoietin	injection, solution, intravenous, subcutaneous	59676-340BLA
-	Polyethylene Glycol 400	solution	12578-117DRUG FOR FURTHER PROCESSING
REMICADE	INFLIXIMAB	injection, powder, lyophilized, for solution, intravenous	57894-030BLA
RISPERDAL	risperidone	tablet, oral	50458-300NDA
RISPERDAL	risperidone	tablet, oral	50458-302NDA
RISPERDAL	risperidone	solution, oral	50458-305NDA
RISPERDAL	risperidone	tablet, oral	50458-320NDA
RISPERDAL	risperidone	tablet, oral	50458-330NDA
RISPERDAL	risperidone	tablet, oral	50458-350NDA
RISPERDAL CONSTA	risperidone	kit	50458-306NDA
RISPERDAL CONSTA	risperidone	kit	50458-307NDA
RISPERDAL CONSTA	risperidone	kit	50458-308NDA
RISPERDAL CONSTA	risperidone	kit	50458-309NDA
RISPERDAL M-TAB	risperidone	tablet, orally disintegrating, oral	50458-315NDA
RISPERDAL M-TAB	risperidone	tablet, orally disintegrating, oral	50458-325NDA
RISPERDAL M-TAB	risperidone	tablet, orally disintegrating, oral	50458-335NDA
RISPERDAL M-TAB	risperidone	tablet, orally disintegrating, oral	50458-355NDA
RISPERDAL M-TAB	risperidone	tablet, orally disintegrating, oral	50458-395NDA
-	Rilpivirine	powder	12578-622BULK INGREDIENT
-	Risperidone	powder	12578-303BULK INGREDIENT
Risperidone	risperidone	solution, oral	50458-596NDA
Rybrevant	amivantamab-vmjw	injection, intravenous	57894-501BLA
Rybrevant Faspro	AMIVANTAMAB and HYALURONIDASE-lpuj (HUMAN RECOMBINANT)	injection, subcutaneous	57894-510BLA
Rybrevant Faspro	AMIVANTAMAB and HYALURONIDASE-lpuj (HUMAN RECOMBINANT)	injection, subcutaneous	57894-514BLA
Rybrevant Faspro	AMIVANTAMAB and HYALURONIDASE-lpuj (HUMAN RECOMBINANT)	injection, subcutaneous	57894-515BLA
Rybrevant Faspro	AMIVANTAMAB and HYALURONIDASE-lpuj (HUMAN RECOMBINANT)	injection, subcutaneous	57894-522BLA
SIMPONI ARIA	golimumab	solution, intravenous	57894-350BLA
SIRTURO	Bedaquiline Fumarate	tablet, oral	59676-701NDA
SIRTURO	Bedaquiline Fumarate	tablet, oral	59676-702NDA
SPORANOX	ITRACONAZOLE	capsule, oral	50458-290NDA
STELARA	ustekinumab	injection, solution, subcutaneous	57894-060BLA
STELARA	ustekinumab	injection, solution, subcutaneous	57894-061BLA
Simponi	golimumab	injection, solution, subcutaneous	57894-070BLA
Simponi	golimumab	injection, solution, subcutaneous	57894-071BLA
Spravato	Esketamine Hydrochloride	solution, nasal	50458-028NDA
Stelara	ustekinumab	solution, intravenous	57894-054BLA
Symtuza	Darunavir, Cobicistat, Emtricitabine, and Tenofovir alafenamide	tablet, film coated, oral	59676-800NDA
TALVEY	talquetamab	injection, subcutaneous	57894-469BLA
TALVEY	talquetamab	injection, subcutaneous	57894-470BLA
TECVAYLI	teclistamab-cqyv	injection, subcutaneous	57894-449BLA
TECVAYLI	teclistamab-cqyv	injection, subcutaneous	57894-450BLA
TREMFYA	Guselkumab	injection, subcutaneous	57894-640BLA
TREMFYA	Guselkumab	injection, intravenous	57894-650BLA
TREMFYA	guselkumab	injection, subcutaneous	57894-651BLA
Topamax	topiramate	tablet, coated, oral	50458-639NDA
Topamax	topiramate	tablet, coated, oral	50458-640NDA
Topamax	topiramate	tablet, coated, oral	50458-641NDA
Topamax	topiramate	tablet, coated, oral	50458-642NDA
Topamax	topiramate	capsule, coated pellets, oral	50458-645NDA
Topamax	topiramate	capsule, coated pellets, oral	50458-647NDA
VERMOX	mebendazole	tablet, chewable, oral	50458-675NDA
XARELTO	rivaroxaban	tablet, film coated, oral	50458-577NDA
XARELTO	Rivaroxaban	kit	50458-584NDA
Xarelto	rivaroxaban	granule, for suspension, oral	50458-575NDA
Xarelto	rivaroxaban	tablet, film coated, oral	50458-578NDA
Xarelto	rivaroxaban	tablet, film coated, oral	50458-579NDA
Xarelto	rivaroxaban	tablet, film coated, oral	50458-580NDA
YONDELIS	Trabectedin	injection, powder, lyophilized, for solution, intravenous	59676-610NDA
Zytiga	abiraterone acetate	tablet, oral	57894-150NDA
Zytiga	Abiraterone acetate	tablet, film coated, oral	57894-195NDA
ustekinumab	ustekinumab	injection, solution, subcutaneous	57894-440BLA
ustekinumab	ustekinumab	injection, solution, subcutaneous	57894-441BLA
ustekinumab	ustekinumab	solution, intravenous	57894-444BLA

Compare

Other companies listing risperidone

Cardinal Health 418, Inc.34 sites · 833 NDC
Lupin Limited14 sites · 506 NDC
Zydus Lifesciences Limited12 sites · 717 NDC
Teva Pharmaceutical Industries Ltd.6 sites · 668 NDC
Cadila Pharmaceuticals Limited3 sites · 128 NDC
Alkermes, Inc.2 sites · 21 NDC
Proficient Rx LP1 site · 1,729 NDC
RemedyRepack, Inc1 site · 1,521 NDC
Zydus Pharmaceuticals USA Inc.1 site · 626 NDC
Amneal Ireland Limited1 site · 513 NDC

Enquiry

Common questions

Is Janssen Pharmaceuticals, Inc. FDA approved?: Janssen Pharmaceuticals, Inc. holds no registered establishment of its own; 149 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
What drugs does Janssen Pharmaceuticals, Inc. make?: 149 products are listed under Janssen Pharmaceuticals, Inc. in the openFDA NDC Directory, most often as tablet, film coated; injection; powder. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Are any Janssen Pharmaceuticals, Inc. products in shortage?: 4 presentations are currently listed in the FDA drug shortage database under Janssen Pharmaceuticals, Inc., covering Methylphenidate Hydrochloride Tablet, Extended Release.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.